Craving
50
10
10
23
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.0%
3 terminated out of 50 trials
88.5%
+2.0% vs benchmark
2%
1 trials in Phase 3/4
39%
9 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (50)
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
Endotoxin Exposure to Examine the Role of Inflammation in Alcohol Use
Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving
Theta Burst Stimulation as a Tool to Decrease Drinking in Treatment-seeking Alcohol Users
Probenecid Administration for Alcohol Craving and Consumption
Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder
tDCS for Social Media Addiction
State-dependent Interoception, Value-based Decision-making, and Introspection
Examining the Effectiveness of Dynamic Visual Noise (DVN) for Reducing Alcohol Cravings and Consumption in College Students
Neurofeedback Based on Near-infrared Spectroscopy as a Therapy for Food Addiction in Obese Subjects.
Efficacy of a Cognitive - Affective - Addictive Based Intervention to Decrease Food Craving in Obese Patients.
Cognitive and Affective Mechanisms Underlying an Olfactory Approach to Modify Cigarette Craving
Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation
Evaluation of the Added Value of Sophrology on the Intensity of Craving During Smoking Withdrawal
An Inflammatory Challenge Using Endotoxin
Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder
Electroencephalographic Biofeedback Therapy in Heroin Craving
Using Neurofeedback to Understand the Relationship Between Stress and Alcohol Consumption
Postprandial Metabolic and Appetite Responses to Different Food Intake Sequences in Athletes
tDCS to Decrease Opioid Relapse (UG3)